tirzepatide wegovy or ozempic Compare GLP-1 Options | v Mounjaro | WeightWatchers How Do Ozempic, Mounjaro, Wegovy,

However, there is a clear hierarchy of efficacies in the GLP-1 receptor agonist class, with specific medications offering greater benefits in glycemic control and body weight reductions [1]

Effects of tirzepatide versus insulin glargine on cystatin Cbased kidney function: a SURPASS4 post hoc analysis

C., Parish, M

Additionally, semaglutide increases insulin secretion in response to meals while simultaneously reducing glucagon release, both of which help stabilize blood sugar levels

Retatrutide (LY3437943) is an investigational GLP-1, GIP, and glucagon triple receptor agonist currently in Phase 2 clinical trials

If prospective studies confirm the benefits suggested by this study, these challenges need to be addressed to facilitate appropriate implementation by rheumatologists